Delee Corp

📍 California, United States🗓 Founded 2017👥 15 employees💰 Last funded Aug 2020
Biotechnology Research🌐 delee.co
Website LinkedIn
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
5
Total investors
1
Early stage
4
Mid stage
0
Late stage
2017
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2017–2020 · investors recorded per year
2017120204
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Delee Corp?
Delee Corp has 5 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage.
When did Delee Corp last raise funding?
The most recent investment in Delee Corp recorded on gritt.io was in August 2020.
When was Delee Corp founded?
Delee Corp was founded in 2017.
What industry is Delee Corp in?
Delee Corp operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Delee Corp based?
Delee Corp is headquartered in California, United States.